We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Polymyositis
From WikEM
Contents
Background
Idiopathic inflammatory myopathy causing symmetric proximal muscle weakness, elevated CK,and characteristic EMG findings
Clinical Features
- Symmetrical proximal muscle weakness with insidious onset
- Generally painless (though 30% have myalgia)
- Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position
- Weak neck extensors causing difficulty of holding head up
- Associated arthralgias
Differential Diagnosis
- Hypokalemia
- Hypophosphatemia
- Thyroid disorder (hypothyroidism or hyperthyroidism)
- Myopathies
- Inclusion body myositis
- Drug Induced myopathies (EtOH, antimalarials, colchicine, antifungals)
Weakness
- Neuromuscular weakness
- UMN:
- Spinal cord disease:
- Infection (Epidural abscess)
- Infarction/ischemia
- Trauma (Spinal Cord Syndromes)
- Inflammation (Transverse Myelitis)
- Degenerative (Spinal muscular atrophy)
- Tumor
- Peripheral nerve disease:
- Guillain-Barre syndrome
- Toxins (Ciguatera)
- Tick paralysis
- DM neuropathy (non-emergent)
- NMJ disease:
- Muscle disease:
- Rhabdomyolysis
- Dermatomyositis
- Polymyositis
- Alcoholic myopathy
- Non-neuromuscular weakness
- Can't miss diagnoses:
- ACS
- Arrhythmia/Syncope
- severe infection/Sepsis
- Hypoglycemia
- Periodic paralysis (electrolyte disturbance, K, Mg, Ca)
- Respiratory failure
- Emergent Diagnoses:
- Symptomatic Anemia
- Severe dehydration
- Hypothyroidism
- Polypharmacy
- Malignancy
- Other causes of weakness and paralysis
- Acute intermittent porphyria (ascending weakness)
- Can't miss diagnoses:
Evaluation
- CBC
- ESR
- CRP
- CK
- Urinalysis
- Consider:
- RF
- ANA
- Anti-Jo-1
Management
- Prednisone 1mg/kg/day for 4-8 weeks until CK returns to reference range
- Followed by prednisone taper
- Other treatments that rheum may prescribe:
- Methotrexate as second line for poor response to corticosteroids
- Other agents with less evidence: IVIG, TNF Inhibitors
Disposition
- Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms
- Very strongly associated with malignancy (~30%), especially:[1]
- Ovarian
- Lung
- Pancreatic
- Stomach
- Colorectal
- Lymphoma
- Bladder
See Also
References
- ↑ Hill CL et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001 Jan 13;357(9250):96-100.
Authors
Kristina Shigyo, Kevin Lu, Ross Donaldson, Claire, Neil Young, Daniel Ostermayer